PEARLNCT07675473
Pre-Emptive Parecoxib Sodium for Pain Control During CT-Guided Lung Nodule Localization
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 14 words Show 4 more changesShow less
- Enrollment closed, study ongoing
- Secondary endpoints: details revised at 3 of 3 entries
- Study description revised
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Pain Intensity Assessed by Visual Analog Scale (VAS)
Timeframe: Immediately after the completion of the CT-guided hook wire puncture (within 5 minutes after the withdrawal of the guide needle).
Secondary (3)
Optimal Dosing Time Window for Pre-Emptive Analgesia
Overall Patient Satisfaction Score
Number of Participants Experiencing Localization-Related Complications
Arms and interventions
Parecoxib SodiumExperimental
Participants in this arm will receive a single intravenous dose of 40mg parecoxib sodium prior to the CT-guided hook wire localization procedure.
Normal SalinePlacebo comparator
Participants in this arm will receive a single intravenous dose of 0.9% normal saline (visually identical to the experimental drug) prior to the CT-guided hook wire localization procedure.
Drugs: PARECOXIB SODIUM, 0.9 % Normal Saline
Sites
1 site in 1 country
- Shanghai Chest HospitalShanghai, Shanghai Municipality, China